| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Landos Biopharma, Inc. | Chief Medical Officer | Restricted Stock Unit | 0 | $0 | $0.6900 | 23 May 2024 | Direct |
| Landos Biopharma, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 0 | 23 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000141588924014335-cataldi-fabio-2024-05-23 | Landos Biopharma, Inc. | 23 May 2024 | 3 | $0 | 4 | Chief Medical Officer | 23 May 2024, 17:45 |
| /report/000120919124004211-cataldi-fabio-2024-02-29 | Landos Biopharma, Inc. | 29 Feb 2024 | 1 | $0 | 4 | Chief Medical Officer | 04 Mar 2024, 16:14 |
| /report/000120919123014634-cataldi-fabio-2023-02-28 | Landos Biopharma, Inc. | 28 Feb 2023 | 2 | $0 | 4 | Chief Medical Officer | 02 Mar 2023, 15:15 |
| /report/000120919122049038-cataldi-fabio-2022-09-05 | Landos Biopharma, Inc. | 05 Sep 2022 | 1 | $0 | 4 | Chief Medical Officer | 07 Sep 2022, 17:09 |
| /report/000120919122049036-cataldi-fabio-2022-09-05 | Landos Biopharma, Inc. | 05 Sep 2022 | 0 | $0 | 3 | Chief Medical Officer | 07 Sep 2022, 17:06 |